Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/2012 → 31/01/2014 |
Collaborative partners
- King's College London (lead)
- GSTT Guy's and St Thomas' NHS Foundation Trust
- Institute of Cancer Research
A randomised Phase II feasibility trial of [18f] flurothymidine and [18f]FDG in the assessment of systemic therapy response in triple negative breast cancer and its utility compared to conventional MRI imaging response, early aDC change and biopsy derived biomarkers
- Tutt, Andrew (Primary Investigator)
- Goh, Vicky (Co-Investigator)
- O'Doherty, Michael (Co-Investigator)
- Pinder, Sarah (Co-Investigator)
Project: Research